Ofatumumab in advanced stage chronic lymphocytic leukaemia: results of the UK named patient compassionate use programme.

Схожие документы

• UK experience of Ofatumumab in refractory B-CLL
  по: Varghese, A, и др.
  Опубликовано: (2011)
• Lenalidomide, dexamethasone and alemtuzumab or ofatumumab in high-risk chronic lymphocytic leukaemia: final results of the NCRI CLL210 trial
  по: Andrew R. Pettitt, и др.
  Опубликовано: (2020-02-01)
• Ofatumumab plus chlorambucil versus chlorambucil alone in patients with untreated chronic lymphocytic leukaemia (CLL): results of the phase III study COMPLEMENT 1 (OMB110911; NCRN-adopted)
  по: Hillmen, P, и др.
  Опубликовано: (2014)
• Premature Ventricular Contractions and Cardiomyopathy while on Ofatumumab for Treatment of Chronic Lymphocytic Leukaemia
  по: Oladipo Odeyinka, и др.
  Опубликовано: (2022-11-01)
• Guidelines on the diagnosis, investigation and management of chronic lymphocytic leukaemia.
  по: Oscier, D, и др.
  Опубликовано: (2012)